Heme Review | A Future Of Medicine @HemeReview | Uploaded 4 years ago | Updated 1 hour ago
When I say future, I mean many hundreds of years.
The Farmer Who Removed His Melanoma With A Pocket Knife ▶️youtu.be/bxGS07U-B98
The Truth About The Hydroxychloroquine Study ▶️ youtu.be/smI60BngTns
Chinese Doctors Explain▶️youtu.be/b4zely3ofBk

Audio version of Heme👏Review👏Podcast ▶️https://anchor.fm/chubbyemu

Tweet me: twitter.com/HemeReview
IG me: instagram.com/HemeReview

Music by @Lifeformed

References:
[0] Chapman PB et. al. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.Ann Oncol. 2017 Oct 1;28(10):2581-2587. ncbi.nlm.nih.gov/pubmed/28961848

[1] Chapman PB. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 2011; 364:2507-2516. nejm.org/doi/full/10.1056/NEJMoa1103782

[2] Amy Harmon. New Drugs Stir Debate on Rules of Clinical Trials. New York Times, September 19, 2010. nytimes.com/2010/09/19/health/research/19trial.html